ROBAEYS, Geert

Email Alert RSS Feed

Profile

Full Name
ROBAEYS, Geert
Email
geert.robaeys@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Nevens, F.

Results 1-15 of 15 (Search time: 0.005 seconds).

Issue DateTitleContributor(s)TypeCat.
12019Prevalence and risk factors of hepatitis B virus infection in Middle-Limburg Belgium, year 2017: Importance of migration.KOC, Ozgur; KREMER, Cécile; BIELEN, Rob; Buscchots, D.; HENS, Niel; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
22018Screening for hepatitis C at the emergency department: Babyboomers should also be screened in BelgiumBIELEN, Rob; KREMER, Cécile; KOC, Ozgur; HENDRICKX, Diana; VANELDEREN, Pascal; HENS, Niel; Nevens, F.; ROBAEYS, GeertJournal ContributionM
32018The burden of viral hepatitis C in key subgroups in Belgium: targets for micro-eliminationBIELEN, Rob; Salomonsson, S.; Toghanian, S.; VENKEN, Koen; Hiver, M.; Matthys, A.; Hendrickx, G.; Jadoul, M.; Nevens, F.; ROBAEYS, Geert; Lazarus, J. V.Journal ContributionM
42018Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesVan Hees, S.; Bourgeois, S.; Van Vlierberghe, Hans; Serste, T.; Francque, S.; Michielsen, P.; Sprengers, D.; Reynaert, H.; Henrion, J.; Dastis, S. Negrin; Delwaide, J.; Lasser, L.; Decaestecker, J.; Orlent, H.; Janssens, F.; ROBAEYS, Geert; Colle, I.; Starkel, P.; Moreno, C.; Nevens, F.; Vanwolleghem, T.Journal ContributionA1
52017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
62017Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantationBIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J.; Nevens, F.Conference MaterialC2
72017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experienceBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
82017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Francque, S.; Verlinden, W.; Brixko, C.; Decaestecker, J.; De Galocsy, C.; Janssens, F.; Cool, M.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionM
92017Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantationBIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van der Merwe, S.; Pirenne, J.; Nevens, F.Journal ContributionM
102017The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceBIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Vanwolleghem, T.; Verlinden, W.; Brixco, C.; Decaestecker, J.; de Galocsy, C.; Janssens, F.; Van Overbeke, L.; Van Steenkiste, C.; D'Heygere, F.; Cool, M.; Wuyckens, K.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
112016Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject DrugsBIELEN, Rob; Verrando, R.; PENDERS, Joris; Oris, E.; Nevens, F.; ROBAEYS, GeertConference MaterialC2
122016Belgian Experience with Direct Acting Antivirals in People Who Inject DrugsBIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cools, Mario; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; D'heygere, F.; COOLS, Wilfried; Nevens, F.; ROBAEYS, GeertConference MaterialC2
132016Experience with Direct Acting Agents for the Treatment of Hepatitis C in Flanders.BIELEN, Rob; ROBAEYS, Geert; Cool, M.; Decaestecker, J.; Janssens, F.; George, C.; Laleman, W.; Verslype, C.; CASSIMAN, David; Van der Merwe, S.; Nevens, F.Conference MaterialC2
142016Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsARAIN, Amber; Bourgeois, S.; de Galocsy, C.; Henrion, J.; Deltenre, P.; d'Heygere, F.; George, C.; Bastens, B.; Van Overbeke, L.; Verrando, R.; BRUCKERS, Liesbeth; Mathei, Catharina; Buntinx, F.; Van Vlierberghe, H.; Francque, S.; Laleman, W.; Moreno, C.; Janssens, F.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
152007Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeksROBAEYS, Geert; De Bie, Jozef; Wichers, Marieke C.; BRUCKERS, Liesbeth; Nevens, F.; Michielsen, Peter; Van Ranst, M.; Buntinx, FrankJournal ContributionA1